Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–38.
Alivernini S, Firestein GS, McInnes IB. The pathogenesis of rheumatoid arthritis. Immunity. 2022;55:2255–70.
Zheng Q, Wang D, Lin R, Chen Y, Xu Z, Xu W. Quercetin is a potential therapy for rheumatoid arthritis via targeting caspase-8 through ferroptosis and pyroptosis. J Inflamm Res. 2023;16:5729–54.
Hong Z, Wang H, Zhang T, Xu L, Zhai Y, Zhang X, et al. The HIF-1/ BNIP3 pathway mediates mitophagy to inhibit the pyroptosis of fibroblast-like synoviocytes in rheumatoid arthritis. Int Immunopharmacol. 2024;127:111378.
Thorin-Trescases N, Thorin E. Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological properties. Expert Rev Mol Med. 2014;16:e17.
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15.
England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036.
Wu D, Luo Y, Li T, Zhao X, Lv T, Fang G, et al. Systemic complications of rheumatoid arthritis: focus on pathogenesis and treatment. Front Immunol. 2022;13:1051082.
Singh JA. Treatment guidelines in rheumatoid arthritis. Rheum Dis Clin North Am. 2022;48:679–89.
Widdifield J. Preventing rheumatoid arthritis: a global challenge. Clin Ther. 2019;41:1355–65.
Horiguchi H, Kadomatsu T, Yamashita T, Yumoto S, Terada K, Sato M, et al. ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis. Commun Biol. 2023;6:965.
Gellen B, Thorin-Trescases N, Sosner P, Gand E, Saulnier PJ, Ragot S, et al. ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients. Diabetologia. 2016;59:2321–30.
Liu X, Qin J, Nie J, Gao R, Hu S, Sun H, et al. ANGPTL2+cancer-associated fibroblasts and SPP1+macrophages are metastasis accelerators of colorectal cancer. Front Immunol. 2023;14:1185208.
Jiang C, Yao S, Guo Y, Ma L, Wang X, Chen Y, et al. Angiopoietin-like protein 2 deficiency promotes periodontal inflammation and alveolar bone loss. J Periodontol. 2022;93:1525–39.
Schwenzer A, Quirke AM, Marzeda AM, Wong A, Montgomery AB, Sayles HR, et al. Association of distinct fine specificities of anti-citrullinated peptide antibodies with elevated immune responses to Prevotella intermedia in a subgroup of patients with rheumatoid arthritis and periodontitis. Arthritis Rheumatol. 2017;69:2303–13.
Yu Z, Yang W, He X, Chen C, Li W, Zhao L, et al. Endothelial cell-derived angiopoietin-like protein 2 supports hematopoietic stem cell activities in bone marrow niches. Blood. 2022;139:1529–40.
Tanoue H, Morinaga J, Yoshizawa T, Yugami M, Itoh H, Nakamura T, et al. Angiopoietin-like protein 2 promotes chondrogenic differentiation during bone growth as a cartilage matrix factor. Osteoarthr Cartil. 2018;26:108–17.
Tardito S, Martinelli G, Soldano S, Paolino S, Pacini G, Patane M, et al. Macrophage M1/M2 polarization and rheumatoid arthritis: a systematic review. Autoimmun Rev. 2019;18:102397.
Hanlon MM, Smith CM, Canavan M, Neto NGB, Song Q, Lewis MJ, et al. Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset. Sci Adv. 2024;10:eadj1252.
Zhang X, Zhang Z, Zhao Y, Jin L, Tai Y, Tang Y, et al. Sodium chloride promotes macrophage pyroptosis and aggravates rheumatoid arthritis by activating SGK1 through GABA receptors Slc6a12. Int J Biol Sci. 2024;20:2922–42.
Liu Z, Wang C, Rathkey JK, Yang J, Dubyak GR, Abbott DW, et al. Structures of the gasdermin D C-terminal domains reveal mechanisms of autoinhibition. Structure. 2018;26:778–84.e3.
Wang JL, Hua SN, Bao HJ, Yuan J, Zhao Y, Chen S. Pyroptosis and inflammasomes in cancer and inflammation. MedComm. 2023;4:e374.
Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6:128.
Yin H, Liu N, Sigdel KR, Duan L. Role of NLRP3 inflammasome in rheumatoid arthritis. Front Immunol. 2022;13:931690.
He X, Wu T, He H, Chen L, Han K, Zheng J, et al. Study of kaempferol in the treatment of rheumatoid arthritis through modulation of the NLRP3/CASP1/GSDMD axis and T-cell activation: based on network pharmacology, single-cell analysis, and experimental validation. Int Immunopharmacol. 2024;143:113357.
Gao J, Zhang H, Yang Y, Tao J. Therapeutic potential of targeting the NLRP3 inflammasome in rheumatoid arthritis. Inflammation. 2023;46:835–52.
Sun-Wang JL, Yarritu-Gallego A, Ivanova S, Zorzano A. The ubiquitin-proteasome system and autophagy: self-digestion for metabolic health. Trends Endocrinol Metab. 2021;32:594–608.
Zhuang N, Li L, Chen S, Wang T. PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control. Cell Death Dis. 2016;7:e2501.
Palikaras K, Tavernarakis N. Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis. Exp Gerontol. 2014;56:182–8.
Liao K, Zeng H, Yang X, He D, Wang B, Yuan J. KCNK5 regulating potassium efflux and inducing pyroptosis in corneal epithelial cells through TNFSF10-mediated autophagy in dry eye. Invest Ophthalmol Vis Sci. 2024;65:34.
Zhang Z, Li M, Li X, Feng Z, Luo G, Wang Y, et al. Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease. J Neuroinflammation. 2024;21:261.
Zhang R, Huang W, Zhao T, Fang J, Chang C, He D, et al. Comprehensive analysis and validation of autophagy-related gene in rheumatoid arthritis. Front Cell Dev Biol. 2025;13:1563911.
Lu Y, Fang YX, Ou-Yang ZM, Wu T, Zhang Q, Zou YW, et al. Deficiency of FUN14 domain-containing 1 enhances the migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis through mitochondrial dysregulation. Cell Signal. 2025;132:111829.
Song H, Liu B, Huai W, Yu Z, Wang W, Zhao J, et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun. 2016;7:13727.
Hirano S, Zhou Q, Furuyama A, Kanno S. Differential regulation of IL-1β and IL-6 release in murine macrophages. Inflammation. 2017;40:1933–43.
Chan D, Zhou Y, Chui CH, Lam KH, Law S, Chan AS, et al. Expression of insulin-like growth factor binding protein-5 (IGFBP5) reverses cisplatin-resistance in esophageal carcinoma. Cells. 2018;7:143.
Adasheva DA, Serebryanaya DV. IGF signaling in the heart in health and disease. Biochemistry. 2024;89:1402–28.
Ji Y, Zhang W, Yang J, Li C. MiR-193b inhibits autophagy and apoptosis by targeting IGFBP5 in high glucose-induced trophoblasts. Placenta. 2020;101:185–93.
Oike Y, Tian Z, Miyata K, Morinaga J, Endo M, Kadomatsu T. ANGPTL2—a new causal player in accelerating heart disease development in the aging. Circ J. 2017;81:1379–85.
Thorin-Trescases N, Thorin E. High circulating levels of ANGPTL2: beyond a clinical marker of systemic inflammation. Oxid Med Cell Longev. 2017;2017:1096385.
Liang F, Zhang F, Zhang L, Wei W. The advances in pyroptosis initiated by the inflammasome in inflammatory and immune diseases. Inflamm Res. 2020;69:159–66.
Shen HH, Yang YX, Meng X, Luo XY, Li XM, Shuai ZW, et al. NLRP3: a promising therapeutic target for autoimmune diseases. Autoimmun Rev. 2018;17:694–702.
Fioravanti A, Tenti S, McAllister M, Chemaly M, Eakin A, McLaughlin J, et al. Exploring the involvement of NLRP3 and IL-1β in osteoarthritis of the hand: results from a pilot study. Mediators Inflamm. 2019;2019:2363460.
Horng T. Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome. Trends Immunol. 2014;35:253–61.
Ma C, Wang J, Hong F, Yang S. Mitochondrial dysfunction in rheumatoid arthritis. Biomolecules. 2022;12:1216.
López-Armada MJ, Fernández-Rodríguez JA, Blanco FJ. Mitochondrial dysfunction and oxidative stress in rheumatoid arthritis. Antioxidants. 2022;11:1151.
Fearon U, Canavan M, Biniecka M, Veale DJ. Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis. Nat Rev Rheumatol. 2016;12:385–97.
Deo P, Chow SH, Han ML, Speir M, Huang C, Schittenhelm RB, et al. Mitochondrial dysfunction caused by outer membrane vesicles from Gram-negative bacteria activates intrinsic apoptosis and inflammation. Nat Microbiol. 2020;5:1418–27.
Li P, Li S, Wang L, Li H, Wang Y, Liu H, et al. Mitochondrial dysfunction in hearing loss: Oxidative stress, autophagy and NLRP3 inflammasome. Front Cell Dev Biol. 2023;11:1119773.
Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221–5.
Chen J, Wu W, Zhang M, Chen C. Taraxasterol suppresses inflammation in IL-1β-induced rheumatoid arthritis fibroblast-like synoviocytes and rheumatoid arthritis progression in mice. Int Immunopharmacol. 2019;70:274–83.
Dai ZZ, Xu J, Zhang Q, Zhou H, Liu XM, Li H. TREM1 interferes with macrophage mitophagy via the E2F1-mediated TOMM40 transcription axis in rheumatoid arthritis. Free Radic Biol Med. 2025;228:267–80.
Wang H, Shen M, Ma Y, Lan L, Jiang X, Cen X, et al. Novel mitophagy inducer alleviates lupus nephritis by reducing myeloid cell activation and autoantigen presentation. Kidney Int. 2024;105:759–74.
Lassen KG, Xavier RJ. Mechanisms and function of autophagy in intestinal disease. Autophagy. 2018;14:216–20.
Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524:309–14.
Yamashita SI, Sugiura Y, Matsuoka Y, Maeda R, Inoue K, Furukawa K, et al. Mitophagy mediated by BNIP3 and NIX protects against ferroptosis by downregulating mitochondrial reactive oxygen species. Cell Death Differ. 2024;31:651–61.
Allard JB, Duan C. IGF-binding proteins: why do they exist and why are there so many? Front Endocrinol. 2018;9:117.
Stockhammer A, Adarska P, Natalia V, Heuhsen A, Klemt A, Bregu G, et al. ARF1 compartments direct cargo flow via maturation into recycling endosomes. Nat Cell Biol. 2024;26:1845–59.
Kourkoulou A, Martzoukou O, Fischer R, Amillis S. A type II phosphatidylinositol-4-kinase coordinates sorting of cargo polarizing by endocytic recycling. Commun Biol. 2024;7:855.
Ofuchi T, Otsu H, Hosoda K, Ikehara T, Tsujimoto A, Higuchi S, et al. VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway. J Gastroenterol. 2025;60:1157–73.
Toshima JY, Toshima J. Transport mechanisms between the endocytic, recycling, and biosynthetic pathways via endosomes and the trans-Golgi network. Front Cell Dev Biol. 2024;12:1464337.
Posey AD Jr., Swanson KE, Alvarez MG, Krishnan S, Earley JU, Band H, et al. EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development. Dev Biol. 2014;387:179–90.
Shin S, Wolgamott L, Yoon SO. Integrin trafficking and tumor progression. Int J Cell Biol. 2012;2012:516789.
Gao R, Wang H, Li T, Wang J, Ren Z, Cai N, et al. Secreted MUP1 that reduced under ER stress attenuates ER stress-induced insulin resistance through suppressing protein synthesis in hepatocytes. Pharmacol Res. 2023;187:106585.
Baines AC, Adams EJ, Zhang B, Ginsburg D. Disruption of the Sec24d gene results in early embryonic lethality in the mouse. PLoS ONE. 2013;8:e61114.
Horiguchi H, Kadomatsu T, Kurahashi R, Hara C, Miyata K, Baba M, et al. Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunity. Genes Dev. 2019;33:1641–56.
Osumi H, Horiguchi H, Kadomatsu T, Tashiro K, Morinaga J, Takahashi T, et al. Tumor cell-derived angiopoietin-like protein 2 establishes a preference for glycolytic metabolism in lung cancer cells. Cancer Sci. 2020;111:1241–53.
Horiguchi H, Endo M, Miyamoto Y, Sakamoto Y, Odagiri H, Masuda T, et al. Angiopoietin-like protein 2 renders colorectal cancer cells resistant to chemotherapy by activating spleen tyrosine kinase-phosphoinositide 3-kinase-dependent anti-apoptotic signaling. Cancer Sci. 2014;105:1550–9.
Wang D, Guo Y, Chai S, Shen K, Li Y, Zhao R. Expression of angiopoietin-like protein 2 in ovarian tissue of rat polycystic ovarian syndrome model and its correlation study. Reprod Biol Endocrinol. 2020;18:94.
Ock J, Suh JK, Hong SS, Kang JH, Yin GN, Ryu JK. IGFBP5 antisense and short hairpin RNA (shRNA) constructs improve erectile function by inducing cavernosum angiogenesis in diabetic mice. Andrology. 2023;11:358–71.
Ghafouri-Fard S, Abak A, Mohaqiq M, Shoorei H, Taheri M. The interplay between non-coding RNAs and insulin-like growth factor signaling in the pathogenesis of neoplasia. Front Cell Dev Biol. 2021;9:634512.
Wang J, Ding N, Li Y, Cheng H, Wang D, Yang Q, et al. Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells. Oncotarget. 2015;6:20636–49.
Henson SM, Lanna A, Riddell NE, Franzese O, Macaulay R, Griffiths SJ, et al. p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8⁺ T cells. J Clin Invest. 2014;124:4004–16.
Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, et al. Strategies toward rheumatoid arthritis therapy: the old and the new. J Cell Physiol. 2019;234:10018–31.
Qindeel M, Ullah MH, Fakhar Ud D, Ahmed N, Rehman AU. Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy. J Control Release. 2020;327:595–615.
Grove ML, Hassell AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. Qjm. 2001;94:309–19.
Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem. 2018;158:502–16.
Johnson S, Katyal N, Narula N, Govindarajan R. Adverse side effects associated with corticosteroid therapy: a study in 39 patients with generalized myasthenia gravis. Med Sci Monit. 2021;27:e933296.
Kim JW, Choe JY, Park SH. Metformin and its therapeutic applications in autoimmune, inflammatory, rheumatic, and other disease. Korean J Intern Med. 2022;37:13–26.
Laragione T, Gulko PS. mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis. Mol Med. 2010;16:352–8.
Cejka D, Hayer S, Niederreiter B, Sieghart W, Fuereder T, Zwerina J, et al. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis. Arthritis Rheum. 2010;62:2294–302.
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18:e3000410.
Inglis JJ, Simelyte E, McCann FE, Criado G, Williams RO. Protocol for the induction of arthritis in C57BL/6 mice. Nat Protoc. 2008;3:612–8.
Huang P, Yang G, Zhang P, Zhu Y, Guan Y, Sun J, et al. MAPK4 inhibits the early aberrant activation of B cells in rheumatoid arthritis by promoting the IRF4-SHIP1 signaling pathway. Cell Death Dis. 2025;16:43.
Jia N, Ma H, Zhang T, Wang L, Cui J, Zha Y, et al. Gentiopicroside attenuates collagen-induced arthritis in mice via modulating the CD147/p38/NF-κB pathway. Int Immunopharmacol. 2022;108:108854.
Wang L, Aschenbrenner D, Zeng Z, Cao X, Mayr D, Mehta M, et al. Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice. Nat Genet. 2021;53:500–10.
Rong K, Wang D, Pu X, Zhang C, Zhang P, Cao X, et al. Inflammatory macrophage-derived itaconate inhibits DNA demethylase TET2 to prevent excessive osteoclast activation in rheumatoid arthritis. Bone Res. 2025;13:60.
Guiducci C, Gong M, Cepika AM, Xu Z, Tripodo C, Bennett L, et al. RNA recognition by human TLR8 can lead to autoimmune inflammation. J Exp Med. 2013;210:2903–19.
Yang Q, Zhao W, Chen Y, Chen Y, Shi J, Qin R, et al. RelA/MicroRNA-30a/NLRP3 signal axis is involved in rheumatoid arthritis via regulating NLRP3 inflammasome in macrophages. Cell Death Dis. 2021;12:1060.
Yan Y, Tao H, He J, Huang SY. The HDOCK server for integrated protein-protein docking. Nat Protoc. 2020;15:1829–52.
